Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.

Original publication

DOI

10.1016/j.cell.2006.12.010

Type

Journal article

Journal

Cell

Publication Date

29/12/2006

Volume

127

Pages

1304 - 1306

Keywords

Animals, Blood Vessels, Bone Marrow Transplantation, Disease Models, Animal, Dogs, Humans, Mice, Muscular Dystrophies, Stem Cell Transplantation, Stem Cells